Literature DB >> 11323135

The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles.

A L Oaklander1.   

Abstract

The mechanisms of chronic neuropathic pain are not well understood. Postherpetic neuralgia (PHN), which occurs in some patients after shingles (herpes zoster), was used to investigate the neural determinants of chronic pain. Skin biopsies were obtained from 38 adults with or without PHN at least 3 months after healing of shingles on the torso. Vertical sections were immunolabeled against PGP9.5, a pan-axonal marker, to measure the density of remaining nerve endings in skin previously affected by shingles. All axons that end in the epidermis are nociceptors, neurons that transmit pain messages. The densities ranged between 2 and 3976 neurites/mm2 skin surface, but the overlap between subjects and without PHN was small. Of 19 subjects without PHN, 17 had more than 670 neurites/mm2 skin surface area (mean +/- SEM = 1569 +/- 230), and 18 of 19 subjects with PHN had 640 or fewer neurites/mm2 (mean +/- SEM = 367 +/- 92). PHN may be a 'phantom-skin' pain associated with loss of nociceptors. This threshold of approximately 650 neurites/mm2 skin surface was not detected in previous studies that used summary statistics. It implies that the absence of pain after shingles may require the preservation of a minimum density of primary nociceptive neurons, and that the density of epidermal innervation may provide an objective correlate for the presence or absence of PHN pain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11323135     DOI: 10.1016/s0304-3959(00)00481-4

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  54 in total

1.  [Diagnostic comparison of thermal parameters of quantitative sensory testing and laser stimulation in postherpetic neuralgia].

Authors:  M Franz; A Ritter; C Puta; W H R Miltner; T Weiss
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107

2.  Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells.

Authors:  Chiang Siau; Wenhua Xiao; Gary J Bennett
Journal:  Exp Neurol       Date:  2006-06-22       Impact factor: 5.330

3.  Quantification of neural protein in extirpated tooth pulp.

Authors:  Curt A Warren; LeePeng Mok; Sharon Gordon; Ashraf F Fouad; Michael S Gold
Journal:  J Endod       Date:  2007-11-26       Impact factor: 4.171

Review 4.  Herpes zoster and postherpetic neuralgia: past, present and future.

Authors:  Gary J Bennett; C Peter N Watson
Journal:  Pain Res Manag       Date:  2009 Jul-Aug       Impact factor: 3.037

Review 5.  The role of sensory fiber demography in trigeminal and postherpetic neuralgias.

Authors:  A F DaSilva; M F DosSantos
Journal:  J Dent Res       Date:  2011-06-13       Impact factor: 6.116

6.  Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain.

Authors:  D M Cain; P W Wacnik; M Turner; G Wendelschafer-Crabb; W R Kennedy; G L Wilcox; D A Simone
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

Review 7.  [Postherpetic neuralgia].

Authors:  G Goßrau
Journal:  Schmerz       Date:  2014-02       Impact factor: 1.107

8.  Effects of distal nerve injuries on dorsal-horn neurons and glia: relationships between lesion size and mechanical hyperalgesia.

Authors:  J W Lee; S M Siegel; A L Oaklander
Journal:  Neuroscience       Date:  2008-10-11       Impact factor: 3.590

9.  Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine.

Authors:  Jessica A Boyette-Davis; Juan P Cata; Larry C Driver; Diane M Novy; Brian M Bruel; Deidre L Mooring; Gwen Wendelschafer-Crabb; William R Kennedy; Patrick M Dougherty
Journal:  Cancer Chemother Pharmacol       Date:  2012-12-11       Impact factor: 3.333

Review 10.  Understanding Neuropathic Corneal Pain--Gaps and Current Therapeutic Approaches.

Authors:  Sunali Goyal; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2016       Impact factor: 1.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.